Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pirbright supports global battle against COVID-19
More than 60 of Pirbright's diagnostic staff and scientists have volunteered to join the PHE COVID-19 testing effort.
Scientists utilising skills and equipment to support the testing effort

Researchers at The Pirbright Institute are utilising their unique facilities and expertise to help in the global battle against COVID-19.

Scientists are providing help in three key areas, allowing the UK to increase its capacity to test both NHS staff and patients and meet the Government’s pledge to deliver 100,000 COVID-19 diagnostic tests by the end of April.

Pirbright has supplied the UK's National Coronavirus Testing Centre in Milton Keynes with 13 of its high-throughput testing machines. Comprising seven nucleic acid extraction robots and six PCR machines, the equipment will be used to identify the presence of COVID-19 in samples taken from potentially infected people and/or healthcare workers.

Furthermore, more than 60 of Pirbright’s diagnostic staff and scientists have volunteered to join the testing effort at seven Public Health England testing sites across the nation. The volunteers have been working away from their families since 23 March and will be deployed on a rota basis for as long as is required.

Pirbright scientists with expertise in animal coronaviruses are also studying the virus (SARS-CoV-2) that causes COVID-19 to further understand its biology and how it infects cells. A vaccine trial is already underway, in which a potential vaccine is being tested on pigs.

“This work is a fantastic collaboration between world-leading medical and veterinary scientists in immunology, virology and molecular biology,” explained Dr Toby Tuthill, head of the virus programme at Pirbright.

“It will provide an evaluation of new SARS-CoV-2 vaccines in a relevant model and will also generate a panel of antibody-based tools which will help us understand virus structure and how it stimulates the immune response. These antibodies could also be developed as additional novel therapeutics to treat COVID-19”, he said.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.